在与代谢功能障碍相关的脂肪性肝病 (MASLD) 中,补充相关蛋白质的早期升高与正常的肝酶
Li Shao1,2, Binbin Zhang1,3, Jing Liu3
1School of Clinical Medicine, Hangzhou Normal University, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
BMC gastroenterology
|October 30, 2025
概括
具有正常酶水平的代谢功能障碍相关的脂肪性肝病 (MASLD) 显示了早期的补体系统激活. 这一发现在MASLD患者和小鼠模型中表明了早期肝病的新治疗点.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 影响全球四分之一的人口.
- 较轻度的MASLD病例,肝酶水平正常,研究不足.
- 了解MASLD的早期分子事件对于及时干预至关重要.
研究的目的:
- 为了研究MASLD患者的分子变化,呈现正常的肝酶水平.
- 确定早期生物标志物和涉及MASLD进展的途径.
主要方法:
- 来自MASLD患者和健康对照的血清样本的蛋白质组分析.
- 在MASLD患者与正常肝酶 (MASLD-NLE) 和高脂肪饮食诱导的小鼠模型 (小鼠-NLE) 的独立队列中验证.
- 人类和小鼠样本中关键蛋白质水平的ELISA确认.
主要成果:
- 尽管酶水平正常,但MASLD-NLE患者的ALT,AST,γGGT,hs-CRP,尿酸和肌酸水平升高.
- 血清蛋白质学揭示了MASLD-NLE中补充蛋白C3和CFH水平的显著增加.
- C3和CFH水平与炎症标志物和肝酶正相关,并在小鼠NLE中得到证实.
结论:
- 补体系统在早期的MASLD中被激活,即使是正常的肝酶.
- 升高的C3和CFH可以作为早期MASLD检测的潜在生物标志物.
- 向补充激活为MASLD提供了一个新的治疗策略.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
Liver Physiology
3.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.5K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
209
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
209
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Inborn Errors of Metabolism
690
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
690
Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K


